Assessment of Asthma Control Level in Malaysia
ASCORE
A Non-Interventional Retrospective Study To Assess The Level Of Asthma Control Among Adults at 2 Tertiary Care Centres In Malaysia
1 other identifier
observational
398
1 country
2
Brief Summary
A Non-Interventional Retrospective Study To Assess The Level Of Asthma Control Among Adults at 2 Tertiary Care Centres In Malaysia; Institute Of Respiratory Medicine (IPR) And Hospital Serdang. The specific objective of the study is to assess, in real-life clinical practice in Malaysia, the level of GINA-defined asthma control and the potential risk factors for uncontrolled disease in asthma patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2017
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 5, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 5, 2017
CompletedFirst Submitted
Initial submission to the registry
August 29, 2017
CompletedFirst Posted
Study publicly available on registry
September 27, 2017
CompletedMay 11, 2018
May 1, 2018
3 months
August 29, 2017
May 7, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Level of GINA-defined asthma control
To assess, in real-life clinical practice in Malaysia, the level of GINA-defined asthma control and the potential risk factors for uncontrolled disease in asthma patients
up to 8 months
Secondary Outcomes (2)
Types of medication prescribed for asthma control
up to 8 months
Asthma control level
up to 8 months
Study Arms (1)
GINA-defined clinical diagnosis of Asthma
All patients with GINA-defined clinical diagnosis of Asthma seen at respiratory clinic from January to August 2016 with age 18 and above
Eligibility Criteria
Tertiary Care Centre ( patients seen at outpatient physicians )
You may qualify if:
- All patients with GINA-defined clinical diagnosis of Asthma seen at respiratory clinic from January to August 2016.
- Be at least 18 years of age
You may not qualify if:
- Clinical features suggesting emphysema or chronic bronchitis
- Other de-compensated organ failures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (2)
Institut Perubatan Respiratori
Kuala Lumpur, Kuala Lumpur, Malaysia
Hospital Serdang
Kajang, Selangor, Malaysia
Related Links
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 29, 2017
First Posted
September 27, 2017
Study Start
January 3, 2017
Primary Completion
April 5, 2017
Study Completion
April 5, 2017
Last Updated
May 11, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share
N/A, Non interventional Study , observational study. No patient involved